ABSTRACT
Scleredema diabeticorum is an uncommon condition. It is one of the cutaneous manifestations in diabetes mellitus that mainly occurs in obese middle-aged men with insulin-resistant diabetes. This condition is generally recalcitrant to therapy. Various treatments have been tried with inconsistent results. Here, we describe two cases of scleredema diabeticorum with substantial clinical improvement from a course of medium dose (60 J/cm²) ultraviolet A1 radiation therapy.
Subject(s)
Diabetes Mellitus, Type 2/complications , Scleredema Adultorum/radiotherapy , Ultraviolet Therapy , Adult , Aged , Humans , Male , Radiotherapy Dosage , Scleredema Adultorum/etiology , Treatment OutcomeABSTRACT
Delayed pressure urticaria (DPU) is characterized by swellings that develop at sites of sustained pressure on the skin several hours after the pressure is removed and can persist for days. DPU is generally difficult to treat successfully. Antihistamines are usually not effective. We present the case of a patient with DPU who appeared to benefit from chloroquine.
Subject(s)
Chloroquine/therapeutic use , Urticaria/drug therapy , Adult , Amebicides/therapeutic use , Antimalarials/therapeutic use , Antirheumatic Agents/therapeutic use , Humans , Male , Pressure , Recurrence , Skin/drug effects , Skin/pathology , Skin/physiopathology , Treatment Outcome , Urticaria/diagnosis , Urticaria/physiopathologyABSTRACT
The purpose of our study was to assess the prevalence and clinical course of patients with chronic idiopathic urticaria (CIU), as well as possible causes or associated findings, laboratory findings and the duration of the disease in patients with chronic urticaria (CU). We retrospectively reviewed the 450 case record forms of patients with CU and/or angioedema who attended the Department of Dermatology, Siriraj Hospital, during the period 2000-2004. Of 450 patients with CU, 337 patients (75%) were diagnosed as CIU. Forty-three patients (9.5%) had physical urticaria, while 17 patients (3.8%) had infectious causes. Other possible causes were food, thyroid diseases, atopy, drugs, dyspepsia and collagen vascular diseases. In eighty-nine percent of patients, no abnormalities were detected at the time of physical examination. The most common abnormal laboratory finding was minimal elevation of the erythrocyte sedimentary rate (42%). In 61 patients, autologous serum skin tests had been done. Fifteen patients (24.5%) had positive results i.e. autoimmune urticaria. Anti-thyroglobulin and anti-microsomal antibodies were positive in 16 % and 12% of CIU patients respectively. After 1 year from the onset of the symptoms, 34.5% of CIU patients were free of symptoms and after 1.2 years from the onset of the symptoms, 56.5% of autoimmune urticaria patients were free of symptoms. The median disease duration of CIU and autoimmune urticaria were 390 days and 450 days respectively. Our study provided an overview of CU and CIU in a large series of Thai patients, based on etiological aspects and clinical courses.
